X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs WOCKHARDT LTD. - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA WOCKHARDT LTD. ABBOTT INDIA/
WOCKHARDT LTD.
 
P/E (TTM) x 33.3 17.2 193.5% View Chart
P/BV x 8.3 1.8 473.9% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ABBOTT INDIA   WOCKHARDT LTD.
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
WOCKHARDT LTD.
Mar-16
ABBOTT INDIA/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs6,0152,000 300.8%   
Low Rs3,707706 525.2%   
Sales per share (Unadj.) Rs1,236.9403.7 306.4%  
Earnings per share (Unadj.) Rs122.229.5 414.6%  
Cash flow per share (Unadj.) Rs129.042.4 304.4%  
Dividends per share (Unadj.) Rs35.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs521.2323.4 161.2%  
Shares outstanding (eoy) m21.25110.51 19.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.93.4 117.3%   
Avg P/E ratio x39.845.9 86.7%  
P/CF ratio (eoy) x37.731.9 118.0%  
Price / Book Value ratio x9.34.2 222.9%  
Dividend payout %28.60-   
Avg Mkt Cap Rs m103,296149,509 69.1%   
No. of employees `0003.07.4 40.1%   
Total wages/salary Rs m3,3709,443 35.7%   
Avg. sales/employee Rs Th8,891.86,048.6 147.0%   
Avg. wages/employee Rs Th1,140.01,280.2 89.0%   
Avg. net profit/employee Rs Th878.3441.5 198.9%   
INCOME DATA
Net Sales Rs m26,28444,614 58.9%  
Other income Rs m504970 52.0%   
Total revenues Rs m26,78945,584 58.8%   
Gross profit Rs m3,6655,038 72.8%  
Depreciation Rs m1441,426 10.1%   
Interest Rs m81,012 0.8%   
Profit before tax Rs m4,0173,570 112.5%   
Minority Interest Rs m0-65 0.0%   
Prior Period Items Rs m06 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,421255 557.7%   
Profit after tax Rs m2,5963,257 79.7%  
Gross profit margin %13.911.3 123.5%  
Effective tax rate %35.47.1 495.6%   
Net profit margin %9.97.3 135.3%  
BALANCE SHEET DATA
Current assets Rs m14,44639,906 36.2%   
Current liabilities Rs m4,72518,423 25.6%   
Net working cap to sales %37.048.2 76.8%  
Current ratio x3.12.2 141.2%  
Inventory Days Days5190 57.0%  
Debtors Days Days2098 19.9%  
Net fixed assets Rs m1,11335,832 3.1%   
Share capital Rs m213553 38.5%   
"Free" reserves Rs m10,80830,370 35.6%   
Net worth Rs m11,07635,739 31.0%   
Long term debt Rs m016,542 0.0%   
Total assets Rs m16,24179,522 20.4%  
Interest coverage x497.04.5 10,976.7%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.60.6 288.5%   
Return on assets %16.05.4 298.7%  
Return on equity %23.49.1 257.2%  
Return on capital %36.38.7 420.0%  
Exports to sales %0.611.6 5.3%   
Imports to sales %12.64.5 283.4%   
Exports (fob) Rs m1625,177 3.1%   
Imports (cif) Rs m3,3221,990 167.0%   
Fx inflow Rs m2687,589 3.5%   
Fx outflow Rs m3,9272,878 136.4%   
Net fx Rs m-3,6594,711 -77.7%   
CASH FLOW
From Operations Rs m2,514716 351.1%  
From Investments Rs m-800-8,182 9.8%  
From Financial Activity Rs m-8032,543 -31.6%  
Net Cashflow Rs m912-4,923 -18.5%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 2.3 343.5%  
FIIs % 0.1 7.7 1.3%  
ADR/GDR % 0.0 0.1 -  
Free float % 17.1 15.4 111.0%  
Shareholders   18,270 67,757 27.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AUROBINDO PHARMA  MERCK LTD  NOVARTIS  FULFORD INDIA  ORCHID PHARMA LTD  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 16, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS